530 related articles for article (PubMed ID: 1735618)
1. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.
Garaci E; Mastino A; Pica F; Favalli C
Cancer Immunol Immunother; 1990; 32(3):154-60. PubMed ID: 2126987
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
[TBL] [Abstract][Full Text] [Related]
4. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
[TBL] [Abstract][Full Text] [Related]
5. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.
Rasi G; Silecchia G; Sinibaldi-Vallebona P; Spaziani E; Pierimarchi P; Sivilia M; Tremiterra S; Garaci E
Int J Cancer; 1994 Jun; 57(5):701-5. PubMed ID: 8194879
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.
Saxton ML; Longo DL; Wetzel HE; Tribble H; Alvord WG; Kwak LW; Leonard AS; Ullmann CD; Curti BD; Ochoa AC
Blood; 1997 Apr; 89(7):2529-36. PubMed ID: 9116299
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).
Tentori L; Leonetti C; Lozupone F; Bonmassar E
Cancer Immunol Immunother; 1995 Dec; 41(6):375-83. PubMed ID: 8635195
[TBL] [Abstract][Full Text] [Related]
10. Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Clin Immunol Immunopathol; 1994 Oct; 73(1):115-22. PubMed ID: 7923908
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide.
Hosokawa M; Sawamura Y; Morikage T; Okada F; Xu ZY; Morikawa K; Itoh K; Kobayashi H
Cancer Immunol Immunother; 1988; 26(3):250-6. PubMed ID: 3260132
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immune response and antitumor immunity with combinations of biological response modifiers.
Garaci E; Mastino A; Favalli C
Bull N Y Acad Med; 1989 Jan; 65(1):111-9. PubMed ID: 2481523
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
[TBL] [Abstract][Full Text] [Related]
14. Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis.
Katsanis E; Bausero MA; Ochoa AC; Loeffler CM; Blazar BR; Leonard AS; Anderson PM
Cancer Immunol Immunother; 1991; 34(2):74-8. PubMed ID: 1760819
[TBL] [Abstract][Full Text] [Related]
15. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
17. In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.
Peppoloni S; Mathieson BJ; Herberman RB; Overton RW; Gorelik E
Cancer Immunol Immunother; 1987; 24(1):49-56. PubMed ID: 2949833
[TBL] [Abstract][Full Text] [Related]
18. Chemo-immunotherapy of murine solid tumors: enhanced therapeutic effects by interleukin-2 combined with interferon alpha and the role of specific T cells.
Kedar E; Rutkowski Y; Leshem B
Cancer Immunol Immunother; 1992; 35(1):63-8. PubMed ID: 1611625
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.
Hadden JW; Saha A; Sosa M; Hadden EM
Int J Immunopharmacol; 1995 Oct; 17(10):821-8. PubMed ID: 8707447
[TBL] [Abstract][Full Text] [Related]
20. Immunochemotherapy in B-16-melanoma-cell-transplanted mice with combinations of interleukin-2, cyclophosphamide, and PSK.
Ueno Y; Kohgo Y; Sakamaki S; Itoh Y; Takahashi M; Hirayama Y; Niitsu Y
Oncology; 1994; 51(3):296-302. PubMed ID: 8196915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
